Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

"We wanted to make a soft material, nanoscale robot with grabbing functions that never have been seen before." Researchers ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...

Breast cancer cases in Americans under 45 years old dramatically increased after the introduction of mRNA COVID-19 vaccines, from approximately 26,000 in 2019-2022 to 297,000 in 2023, a nearly 1,000% ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

A team of chemists and microbiologists at Michigan State University has found that an all-optical method can be used to ...

Harnessing the ultrasonic vibrations of tiny viral particles is leading researchers down new paths of discovery.

Each nanoparticle is tagged with a unique DNA sequence, with which the researchers could tag and track individual designs, much like registering a parcel to be shipped by post in a delivery system.

Flu vs. COVID-19 Like the flu, COVID is also a contagious respiratory infection. But the coronavirus causes COVID, while the influenza virus causes the flu. COVID also spreads faster than the flu ...

No writing assistance was utilized in the production of this manuscript. A nanoparticle's shape and size dictates its rate of margination and its ability to bind to cell membranes. A plethora of ...